Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Dexcom revenue
Dexcom's revenue is $4.0 billion.
What is Dexcom's revenue?
- Dexcom's revenue growth from 2006 to 2024 is 185,752.53%.
- Dexcom has 3,900 employees, and the revenue per employee ratio is $1,034,102.
- Dexcom's peak quarterly revenue was $1.1B in 2024(q4).
- Dexcom peak revenue was $4.0B in 2024.
- Dexcom annual revenue for 2023 was 3.6B, 24.49% growth from 2022.
- Dexcom annual revenue for 2024 was 4.0B, 11.34% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Dexcom historical revenue
Dexcom's peak revenue was $4.0B in 2024. The peak quarterly revenue was $1.1B in 2024(q4).
Dexcom's revenue increased from $2.2m in 2006 to $4.0B currently. That's a 185,752.53% change in annual revenue.
Dexcom annual revenue
Dexcom annual revenue over time
| Fiscal year / year | Dexcom revenue |
|---|---|
| 2009 | $29.7M |
| 2010 | $48.6M |
| 2011 | $76.3M |
| 2012 | $99.9M |
| 2013 | $160.0M |
| 2014 | $259.2M |
| 2015 | $402.0M |
| 2016 | $573.3M |
| 2017 | $718.5M |
| 2018 | $1.0B |
| 2019 | $1.5B |
| 2020 | $1.9B |
| 2021 | $2.4B |
| 2022 | $2.9B |
| 2023 | $3.6B |
| 2024 | $4.0B |
How accurately did Dexcom's revenue projections match actual performance?
Dexcom annual growth
Dexcom saw the greatest revenue growth in 2009, when revenue increased by 201.82%.
Dexcom had the lowest revenue growth in 2022, when revenue changed by 18.84%.
Dexcom annual growth rate over time
| Year | Dexcom growth |
|---|---|
| 2009 | 202%↑ |
| 2010 | 64%↑ |
| 2011 | 57%↑ |
| 2012 | 31%↑ |
| 2013 | 60%↑ |
| 2014 | 62%↑ |
| 2015 | 55%↑ |
| 2016 | 43%↑ |
| 2017 | 25%↑ |
| 2018 | 44%↑ |
| 2019 | 43%↑ |
| 2020 | 31%↑ |
| 2021 | 27%↑ |
| 2022 | 19%↑ |
| 2023 | 24%↑ |
| 2024 | 11%↑ |
Dexcom quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Dexcom quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | - | $170.6M | $184.6M | $221.0M |
| 2018 | $184.4M | $242.5M | $266.7M | $338.0M |
| 2019 | $280.5M | $336.4M | $396.3M | $462.8M |
| 2020 | $405.1M | $451.8M | $500.9M | $568.9M |
| 2021 | $505.0M | $595.1M | $650.2M | $698.2M |
| 2022 | $628.8M | $696.2M | $769.6M | $815.2M |
| 2023 | $741.5M | $871.3M | $975.0M | $1.0B |
| 2024 | $921.0M | $1.0B | $994.2M | $1.1B |
Dexcom jobs nearby
Do you work at Dexcom?
Did Dexcom meet its revenue projections?
Dexcom financial information
| CEO | Kevin Ronald Sayer |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 3,900 |
| Date Founded | 1999 |
| Headquarters | San Diego, California |
| Number of Locations | 4 |
| Revenue | $4.0B |
| Net Income | $341,200,000 |
| Gross Proft | $2.4B (2024) |
| EBITDA | $318.1M (2020) |
| PE Ratio | 21.86 |
| Tax Rate | 0.2% |
| Market Capitalization | $12.6B |
| Total Assets | $5,391,700,000 |
| Ticker | DXCM |
Dexcom jobs you might like
Dexcom financing
Dexcom received early financing of $30.0M on 2002-06-03.
| Series | Round size | Date |
|---|---|---|
| Series C | $30M | 06/2002 |
| Series D | $22.5M | 01/2005 |
| Post Ipo Equity | $4.0M | 04/2012 |
| Post Ipo Equity | $7.2M | 05/2016 |
| Post Ipo Debt | $350M | 05/2017 |
Dexcom investors
| Investors | Security type |
|---|---|
| Canaan Partners | Series C |
| St Paul Venture Capital Inc | Series C |
| Windamere Venture Partners | Series C |
| Federated Kaufmann Fund | Series C |
| RWI Group | Series C |
| Fog City Capital | Series C |
| Canaan Partners | Series D |
| Warburg Pincus | Series D |
| St Paul Venture Capital Inc | Series D |
| RWI Group | Series D |
Dexcom competitors
Dexcom's top competitor, McKesson, earned an annual revenue of $309.0B.
Dexcom's smallest competitor is Integra Seating with revenue of $13.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| NuVasive | $75,654 | $1.2B | 2,800 | - |
| Baxter International | $54,368 | $10.6B | 48,000 | 282 |
| Stryker | $69,470 | $22.6B | 43,000 | 2,146 |
| Intersect ENT | $67,446 | $106.7M | 393 | - |
| ICU Medical | $77,518 | $2.4B | 9,000 | 141 |
| Tandem Diabetes Care | $62,371 | $940.2M | 1,500 | 4 |
| Danaher | $65,463 | $23.9B | 80,000 | 1,664 |
| Hospira | $64,435 | $4.5B | 19,000 | - |
| Amgen | $93,349 | $33.4B | 22,000 | 760 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 591 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Dexcom highest paying jobs
Zippia gives an in-depth look into the details of Dexcom, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dexcom. The employee data is based on information from people who have self-reported their past or current employments at Dexcom. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dexcom. The data presented on this page does not represent the view of Dexcom and its employees or that of Zippia.
Dexcom may also be known as or be related to DEXCOM INC, DexCom Inc, DexCom, Inc., Dexcom and Dexcom, Inc.